5De Rossi A, Rossi L, Laudisi A, et al. Focus on fotemustine[J]. J Exp Clin Cancer Res,2006, 25(4) :461.
6Kreuter J. Nanoparticulate systems for brain delivery of drugs[ J ]. Adv Drug Deliv Rev,2001, 47(1):65.
7Lu W, Zhang Y, Tan YZ, et al. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery[J]. J Control Release,2005, 107(3) :428.
8Lu W, Wan J, She Z, et al. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle [J]. J Control Relea-,2007,118(l):38.
9Liu L, Guo K, Lu J, et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier[J]. Biomaterials,2008,29( 10):1509.
10Peracchia MT, Vauthier C, Puisieux F, et al. Development of sterically stabilized poly( isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol)[J]. J Biomed Mater Res, 1997,34(3) : 317.
7MUTHU M S,LEONG D T,MEI L,et al. Nanotheranos- tics-application and further development of nanomedicine strategies for advanced theranostics [J].Theranostics, 2014,4(6) :660-677.
8白毅.纳米技术改善难溶性药物吸收前景光明[N].中国医药报.2010-06-29(02).
9MATSUMURA Y.The drug discovery by nanomedicine and its clinical experience [J].Jpn J Clin Oncol,2014,44 (6) :515-525.
